The WHO-approved Xpert MTB/XDR test detects Mycobacterium tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide and injectable-drugs directly on specimens.
The genomic characterization of carbapenem-resistant Serratia marcescens at Groote Schuur Hospital in South Africa, indicating the emergence and spread of resistance and virulence in this organism.
Researchers at UCT have become the first in Africa to successfully operationalize clinical metagenomics, a technique that expedites the diagnosis of infectious diseases.
The University of Cape Town’s Institute of Infectious Disease and Molecular Medicine Transformation Committee, has awarded four grants to two professional, administrative support and service staff and to two postdoctoral research fellows.
The TB-CAPT XDR trial, led by Helen Cox and Chad Centner of the University of Cape Town (UCT) in South Africa, will evaluate the use of a new cartridge on GeneXpert, an automated tuberculosis (TB) molecular test.
The TB-CAPT consortium has successfully completed enrolment for the XDR trial, undertaken by clinical sites in Green Point (Cape Town) and Gqeberha (formerly Port Elizabeth), South Africa.
Four women researchers from the University of Cape Town (UCT) were among the seven recognised by the L’Oréal-UNESCO For Women in Science South African National Programme for their excellent contributions to science.
